Follow
Davide Matino
Davide Matino
Verified email at mcmaster.ca
Title
Cited by
Cited by
Year
Aryl hydrocarbon receptor control of a disease tolerance defence pathway
A Bessede, M Gargaro, MT Pallotta, D Matino, G Servillo, C Brunacci, ...
Nature 511 (7508), 184-190, 2014
6992014
Hemophilia A and B: molecular and clinical similarities and differences
G Castaman, D Matino
Haematologica 104 (9), 1702, 2019
1862019
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management
M Franchini, G Castaman, A Coppola, C Santoro, E Zanon, G Di Minno, ...
Blood Transfusion 13 (3), 498, 2015
1002015
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors
A Iorio, D Matino, R D'Amico, M Makris
Cochrane Database of Systematic Reviews, 2010
97*2010
Efanesoctocog alfa prophylaxis for patients with severe hemophilia A
A Von Drygalski, P Chowdary, R Kulkarni, S Susen, BA Konkle, ...
New England Journal of Medicine 388 (4), 310-318, 2023
862023
Positive allosteric modulation of indoleamine 2, 3-dioxygenase 1 restrains neuroinflammation
G Mondanelli, A Coletti, FA Greco, MT Pallotta, C Orabona, A Iacono, ...
Proceedings of the National Academy of Sciences 117 (7), 3848-3857, 2020
732020
Deficiency of immunoregulatory indoleamine 2, 3-dioxygenase 1 in juvenile diabetes
C Orabona, G Mondanelli, MT Pallotta, A Carvalho, E Albini, F Fallarino, ...
JCI insight 3 (6), 2018
632018
Amino acid metabolism as drug target in autoimmune diseases
G Mondanelli, A Iacono, A Carvalho, C Orabona, C Volpi, MT Pallotta, ...
Autoimmunity Reviews 18 (4), 334-348, 2019
612019
Engagement of nuclear coactivator 7 by 3-hydroxyanthranilic acid enhances activation of aryl hydrocarbon receptor in immunoregulatory dendritic cells
M Gargaro, C Vacca, S Massari, G Scalisi, G Manni, G Mondanelli, ...
Frontiers in Immunology 10, 1973, 2019
582019
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII
D Matino, M Gargaro, E Santagostino, MND Di Minno, G Castaman, ...
The Journal of Clinical Investigation 125 (10), 3766-3781, 2015
522015
Ligand Binding and Functional Selectivity of l-Tryptophan Metabolites at the Mouse Aryl Hydrocarbon Receptor (mAhR)
R Nuti, M Gargaro, D Matino, D Dolciami, U Grohmann, P Puccetti, ...
Journal of chemical information and modeling 54 (12), 3373-3383, 2014
502014
AhR-mediated, non-genomic modulation of IDO1 function
MT Pallotta, F Fallarino, D Matino, A Macchiarulo, C Orabona
Frontiers in immunology 5, 497, 2014
502014
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3‐dioxygenase1
R Romani, I Pirisinu, M Calvitti, MT Pallotta, M Gargaro, G Bistoni, ...
Journal of cellular and molecular medicine 19 (7), 1593-1605, 2015
492015
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism
F Fallarino, MT Pallotta, D Matino, M Gargaro, C Orabona, C Vacca, ...
Immunobiology 220 (2), 315-321, 2015
432015
The proteasome inhibitor bortezomib controls indoleamine 2, 3-dioxygenase 1 breakdown and restores immune regulation in autoimmune diabetes
G Mondanelli, E Albini, MT Pallotta, C Volpi, L Chatenoud, C Kuhn, ...
Frontiers in Immunology 8, 428, 2017
402017
Shared topics on the experience of people with haemophilia living in the UK and the USA and the influence of individual and contextual variables: Results from the HERO …
L Palareti, S Potì, F Cassis, F Emiliani, D Matino, A Iorio
International journal of qualitative studies on health and well-being 10 (1 …, 2015
312015
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine
S Bianchini, C Orabona, B Camilloni, MG Berioli, A Argentiero, D Matino, ...
Human vaccines & immunotherapeutics 16 (1), 86-94, 2020
282020
Molecular mechanisms of inhibitor development in hemophilia
P Tieu, A Chan, D Matino
Mediterranean Journal of Hematology and Infectious Diseases 12 (1), 2020
282020
The Function of extravascular coagulation factor IX in haemostasis
DM Mann, KA Stafford, MC Poon, D Matino, DW Stafford
Haemophilia 27 (3), 332-339, 2021
252021
The evolution of hemophilia care: clinical and laboratory advances, opportunities, and challenges
A Trinchero, M Sholzberg, D Matino
Hämostaseologie 40 (03), 311-321, 2020
252020
The system can't perform the operation now. Try again later.
Articles 1–20